Home
Scholarly Works
How it begins: Initial response to opioids...
Preprint

How it begins: Initial response to opioids strongly predicts self-reported opioid use disorder

Abstract

Background Opioid use disorder (OUD) is a major public health crisis. Patients' initial exposure to opioids often comes from prescribed medications. Predicting which of these patients will develop OUD remains challenging. Prior evidence from various substances suggest that initial subjective responses influence addiction risk, however these studies have used relatively small cohorts and have not led to the development of widespread tools to predict OUD risk. Methods We used a cohort of 141,897 adult research participants to perform a retrospective observational study of self-reported subjective responses to prescription opioids. We collected demographics, subjective positive (e.g., euphoria), subjective negative (e.g., nausea), and analgesic responses as well as self-reported OUD. Results Positive subjective effects, particularly "Like Overall", "Euphoric", and "Energized", were the strongest predictors of OUD. For example, the odds-ratio for individuals responding "Extremely" for "Like Overall" was 36.5. The sensitivity and specificity of this single question was excellent (ROC=0.87). Negative effects and analgesic effects were much less predictive. We developed a two-question decision tree ("When you first took opioid pain medication, to what extent did you like the way they made you feel overall?" and "When you first took opioid pain medication, to what extent did you experience an unpleasant itchy feeling?"), that can identify a small high-risk subset with 78.5% prevalence of OUD and a much larger low-risk subset with 1.2% prevalence of OUD. Conclusions Screening for subjective responses can identify high-risk individuals who would benefit from tailored interventions.

Authors

Gonzalez J; Tran V; Meredith J; Xu I; Penchala R; Vilar-Ribó L; Courchesne-Krak N; Zoleikhaeian D; McIntyre M; Fontanillas P

Publication date

March 23, 2025

DOI

10.1101/2025.03.21.25324409

Preprint server

medRxiv
View published work (Non-McMaster Users)

Contact the Experts team